Skip to main content
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

The purpose of this research study is to examine lung cancer patients’ surgically removed tumors for certain genetic changes, and to possibly refer these patients to a treatment study with drugs that may specifically target tumors that have these genetic changes.

Genetic testing will be done to learn if the tumor has any of these genetic changes. This test will look at the genetic material of the tumor cells. All tissues in the body are made up of cells.  Those cells contain DNA, which is the unique genetic material that carries instructions for the body’s development and function.  Cancer can develop when changes in certain genes cause those cells to divide in an uncontrolled way and, sometimes, to travel to other organs. full clinical trial description


  • Principal investigator:
    • Alexander Bershadskiy, MD

  • Secondary investigators:
    • Marcel A. Odaimi, MD
    • Meekoo Dhar, MD
    • Qun Dai, MD
    • Shilpi Gupta, MD
    • Terenig O. Terjanian, MD

  • Coordinators:


Staten Island University Hospital North Campus
475 Seaview AveStaten Island, NY 10305